July 5-7, 2023 – NovAliX were present at the RICT congress held in Lille, France. Organized by The French Medicinal Chemistry Society (Société de Chimie Thérapeutique – SCT).
The conference will focus on “Drug Discovery and Selection” with a range of topics covering from Next Generation of anti-infective agents to late breaking topics.
Great speakers from academia such as Prof. Philippe Karoyan from Sorbonne Université whose talk “Peptide, A manifesto” is very promising. Also outstanding speakers from industry like Eva Caroff from Idorsia Pharmaceuticals or Christel Menet from Confo Therapeutics among many others. Special mention to Christophe Peixoto’s talk “Discovery of GLPG3970, A First-in-class SIK2/SIK3 Inhibitor Evaluated in Clinical Trials for the Treatment of Autoimmune and Inflammatory Diseases” from Galapagos in Romainville newly transfered to NovAliX since July 3rd.
Very excited event where NovAliX is present, so if you are looking for a CRO trusted partner, contact us to set a meeting and catch up at RICT:
Dr. Lutz Paessens, Business Development Associate Director
Dr. Anne de Villeroché, Business Development Associate Director